CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases. The company's lead product candidate is CTX001, an ex-viggered therapy for treating patients suffering from transfusion-dependent beta-thalassemia or severe sickle cell disease. It also develops CTX110, a donor-derived gene-edited allogeneic CAR-T investigational therapy targeting cluster of differentiation 19 positive malignancies.
Market Cap | 3.4 Billion | Shares Outstanding | 78.294 Million | Avg 30-day Volume | 954.775 Thousand |
P/E Ratio | 16.3472 | Dividend Yield | 0.0 | EPS | -8.36 |
Price to Revenue | 6.6584 | Debt to Equity | 0.0 | EBITDA | 397.484 Million |
Price to Book Value | 2.539 | Operating Margin | 40.8244 | Enterprise Value | 3.713 Billion |
Current Ratio | 20.166 | EPS Growth | 1.888 | Quick Ratio | 19.848 |
1 Yr BETA | 1.5347 | 52-week High/Low | 86.95 / 38.94 | Profit Margin | 41.2761 |
Operating Cash Flow Growth | 326.1111 | Altman Z-Score | 12.062 | Free Cash Flow to Firm | 325.258 Million |
Earnings Report | 2023-05-10 |
Please sign in first
none
50 Thousand total shares from 5 transactions
96.8 Thousand total shares from 9 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
PRASAD RAJU CHIEF FINANCIAL OFFICER |
|
0 | 2023-03-14 | 2 |
KULKARNI SAMARTH CHIEF EXECUTIVE OFFICER |
|
1,549,124 | 2023-03-10 | 14 |
KASINGER JAMES R. GENERAL COUNSEL AND SECRETARY |
|
219,225 | 2023-03-10 | 5 |
MORROW PHUONG KHANH CHIEF MEDICAL OFFICER |
|
0 | 2023-03-10 | 4 |
SMITH BRENDAN CHIEF FINANCIAL OFFICER |
|
5,072 | 2023-02-18 | 4 |
KLEIN LAWRENCE OTTO CBO & COO |
|
12,500 | 2022-08-16 | 1 |
|
12,000 | 2022-06-09 | 1 | |
|
0 | 2022-06-09 | 2 | |
|
12,000 | 2022-06-09 | 1 | |
|
12,000 | 2022-06-09 | 1 | |
|
12,000 | 2022-06-09 | 1 | |
|
12,000 | 2022-06-09 | 1 | |
|
12,000 | 2022-06-09 | 1 | |
|
12,000 | 2022-06-09 | 1 | |
HO TONY W EXECUTIVE VP, HEAD OF R&D |
|
130,668 | 2021-12-03 | 0 |
TOMSICEK MICHAEL JOHN CHIEF FINANCIAL OFFICER |
|
132,891 | 2021-08-06 | 0 |
NOVAK RODGER PRESIDENT |
|
573,007 | 2021-06-30 | 0 |
|
0 | 2019-11-19 | 0 | |
|
5,380,940 | 2018-12-26 | 0 | |
|
1,171,268 | 2018-12-18 | 0 | |
|
0 | 2018-06-15 | 0 | |
VERSANT VENTURE CAPITAL V, L.P. VERSANT AFFILIATES FUND V, L.P. |
|
1,729,151 | 2018-04-24 | 0 |
VERSANT VENTURE CAPITAL IV, L.P. VERSANT VENTURE CAPITAL V, L.P. VERSANT AFFILIATES FUND V, L.P. |
|
4,004,248 | 2018-04-20 | 0 |
DYLAN-HYDE TYLER CHIEF LEGAL OFFICER |
|
25,204 | 2018-01-16 | 0 |
|
5,708,747 | 2018-01-05 | 0 | |
|
No longer subject to file | 2017-11-03 | 0 | |
VERSANT VENTURE CAPITAL IV, L.P. VERSANT VENTURE CAPITAL V, L.P. VERSANT AFFILIATES FUND V, L.P. VERSANT OPHTHALMIC AFFILIATES I, L.P. |
|
4,606,242 | 2017-09-05 | 0 |
SUBRAMANIAN KALA SEE REMARKS |
|
85,000 | 2017-06-15 | 0 |
|
0 | 2017-05-31 | 0 | |
|
3,220,627 | 2016-10-24 | 0 | |
VERSANT VENTURE CAPITAL IV, L.P. VERSANT VENTURE CAPITAL V, L.P. VERSANT AFFILIATES FUND V, L.P. |
|
6,909,347 | 2016-10-24 | 0 |
VERSANT VENTURE CAPITAL IV, L.P. |
|
6,758,169 | 2016-10-24 | 0 |
|
No longer subject to file | 2016-10-24 | 0 | |
LUNDBERG SVEN ANTE CHIEF SCIENTIFIC OFFICER |
|
505,617 | 2016-10-24 | 0 |
BECKER MARC CHIEF FINANCIAL OFFICER |
|
0 | 2016-10-18 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-14 17:50:19 -0400 | 2023-03-14 | A | 100,000 | a | 100,000 | direct | ||||||||||
2023-03-14 17:50:19 -0400 | 2023-03-14 | A | 40,000 | a | 40,000 | direct | ||||||||||
2023-03-14 17:45:39 -0400 | 2023-03-13 | F | 1,283 | $43.22 | d | 53,616 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | |||
2023-03-14 17:45:39 -0400 | 2023-03-13 | F | 1,022 | $43.22 | d | 54,844 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | |||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-13 | F | 5,358 | $43.22 | d | 382,463 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | ||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-13 | F | 4,086 | $43.22 | d | 387,377 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | ||
2023-03-14 17:45:39 -0400 | 2023-03-11 | M | 2,250 | a | 55,866 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | ||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-11 | M | 9,000 | d | 18,000 | direct | |||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-11 | M | 9,000 | a | 391,463 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | |||
2023-03-14 17:45:39 -0400 | 2023-03-11 | M | 2,250 | d | 4,500 | direct | ||||||||||
2023-03-14 17:44:07 -0400 | 2023-03-10 | A | 44,620 | a | 44,620 | direct | ||||||||||
2023-03-14 17:45:39 -0400 | 2023-03-10 | M | 2,833 | a | 54,899 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | ||||
2023-03-14 17:45:39 -0400 | 2023-03-10 | M | 2,833 | d | 0 | direct | ||||||||||
2023-03-14 17:45:39 -0400 | 2023-03-10 | A | 22,000 | a | 22,000 | direct | ||||||||||
2023-03-14 17:45:39 -0400 | 2023-03-10 | A | 40,000 | a | 40,000 | direct | ||||||||||
2023-03-14 17:44:07 -0400 | 2023-03-10 | A | 22,000 | a | 22,000 | direct | ||||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-10 | A | 188,000 | a | 188,000 | direct | |||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-10 | M | 11,833 | a | 387,821 | direct | 1.0463 | -3.0721 | 1.8255 | 3 | -3.0721 | 6 | |||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-10 | M | 11,833 | d | 0 | direct | |||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-14 17:47:12 -0400 | 2023-03-10 | A | 77,000 | a | 77,000 | direct | |||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-01 18:11:03 -0500 | 2023-02-27 | M | 25,000 | $19.12 | a | 400,988 | direct | 3.3543 | -6.912 | 3.3543 | 2 | -6.912 | 6 | ||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-01 18:11:03 -0500 | 2023-02-27 | S | 13,720 | $48.57 | d | 377,088 | direct | yes | 3.3543 | -6.912 | 3.3543 | 2 | -6.912 | 6 | |
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-01 18:11:03 -0500 | 2023-02-27 | S | 10,180 | $47.71 | d | 390,808 | direct | yes | 3.3543 | -6.912 | 3.3543 | 2 | -6.912 | 6 | |
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-01 18:11:03 -0500 | 2023-02-27 | S | 1,100 | $49.20 | d | 375,988 | direct | yes | 3.3543 | -6.912 | 3.3543 | 2 | -6.912 | 6 | |
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-03-01 18:11:03 -0500 | 2023-02-27 | M | 25,000 | d | 154,582 | direct | |||||||||
2023-02-22 17:35:46 -0500 | 2023-02-21 | F | 1,950 | $48.26 | d | 52,066 | direct | -4.0368 | -1.6986 | 0.0 | 1 | -4.6363 | 5 | |||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-02-22 17:38:54 -0500 | 2023-02-21 | F | 6,373 | $48.26 | d | 375,988 | direct | -4.0368 | -1.6986 | 0.0 | 1 | -4.6363 | 5 | ||
2023-02-22 17:41:41 -0500 | 2023-02-21 | F | 1,392 | $48.26 | d | 5,072 | direct | -4.0368 | -1.6986 | 0.0 | 1 | -4.6363 | 5 | |||
2023-02-22 17:41:41 -0500 | 2023-02-18 | M | 3,825 | a | 6,464 | direct | -4.0368 | -1.6986 | 0.0 | 1 | -4.6363 | 5 | ||||
2023-02-22 17:35:46 -0500 | 2023-02-18 | M | 3,825 | a | 54,016 | direct | -4.0368 | -1.6986 | 0.0 | 1 | -4.6363 | 5 | ||||
2023-02-22 17:35:46 -0500 | 2023-02-18 | M | 3,825 | d | 11,475 | direct | ||||||||||
2023-02-22 17:41:41 -0500 | 2023-02-18 | M | 3,825 | d | 11,475 | direct | ||||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-02-22 17:38:54 -0500 | 2023-02-18 | M | 13,250 | a | 382,361 | direct | -4.0368 | -1.6986 | 0.0 | 1 | -4.6363 | 5 | |||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-02-22 17:38:54 -0500 | 2023-02-18 | M | 13,250 | d | 39,750 | direct | |||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-01-31 17:34:35 -0500 | 2023-01-27 | M | 25,000 | d | 179,582 | direct | |||||||||
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-01-31 17:34:35 -0500 | 2023-01-27 | M | 25,000 | $19.12 | a | 394,111 | direct | 7.2425 | 2.0256 | -13.262 | 7.2425 | 2 | -17.4088 | 27 | |
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-01-31 17:34:35 -0500 | 2023-01-27 | S | 23,200 | $51.54 | d | 369,111 | direct | yes | 7.2425 | 2.0256 | -13.262 | 7.2425 | 2 | -17.4088 | 27 |
KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER |
2023-01-31 17:34:35 -0500 | 2023-01-27 | S | 1,800 | $50.60 | d | 392,311 | direct | yes | 7.2425 | 2.0256 | -13.262 | 7.2425 | 2 | -17.4088 | 27 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 22:15:03 UTC | 4.5099 | 0.3101 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 21:45:03 UTC | 4.5083 | 0.3117 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 21:15:03 UTC | 4.5083 | 0.3117 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 20:45:03 UTC | 4.4906 | 0.3294 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 20:15:04 UTC | 4.4906 | 0.3294 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 19:45:03 UTC | 4.4906 | 0.3294 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 19:15:04 UTC | 4.4906 | 0.3294 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 18:45:04 UTC | 4.5003 | 0.3197 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 18:15:03 UTC | 4.5003 | 0.3197 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 17:45:03 UTC | 4.5003 | 0.3197 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 17:15:03 UTC | 4.5003 | 0.3197 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 16:45:03 UTC | 4.499 | 0.321 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 16:15:03 UTC | 4.499 | 0.321 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 15:45:03 UTC | 4.499 | 0.321 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 15:15:03 UTC | 4.499 | 0.321 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 14:45:03 UTC | 4.499 | 0.321 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 14:15:03 UTC | 4.499 | 0.321 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 13:45:03 UTC | 4.1693 | 0.4007 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 13:15:04 UTC | 4.1693 | 0.4007 | 600000 |
CRISPR THERAPEUTICS AG CRSP | 2023-03-24 12:45:03 UTC | 4.1693 | 0.4007 | 600000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund | CRSP | -57634.0 shares, $-3016563.56 | 2022-10-31 | N-PORT |